| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document

Title:Ukrepi izbranega farmacevtskega podjetja na področju ponarejanja zdravil : diplomsko delo visokošolskega študijskega programa Varnost in policijsko delo
Authors:Škrgić, Alma (Author)
Modic, Maja (Mentor) More about this mentor... New window
Frangež, Danijela (Co-mentor)
Files:.pdf VS_Skrgic_Alma_2021.pdf (1,15 MB)
MD5: 4F78666BA41E1775CD85CA3A442E47EE
 
Language:Slovenian
Work type:Bachelor thesis/paper (mb11)
Typology:2.11 - Undergraduate Thesis
Organization:FVV - Faculty of Criminal Justice and Security
Abstract:Obstoj ponarejenih medicinskih izdelkov je globalni problem, ki predstavlja nesprejemljivo tveganje za javno zdravje. Škodi pacientom in spodkopava zaupanje v farmacevtsko industrijo, zdravstvene delavce in zdravstveni sistem. Evropska unija je s svojo zakonodajo v zadnjem desetletju naredila velik korak v boju proti ponarejenim zdravilom. Slovenija je zaradi implementacije evropskih predpisov v svoj pravni red leta 2014 izdala nov Zakon o zdravilih. Svet Evrope verjame, da je za uspešen boj proti distribuciji ponarejenih zdravil ključno mednarodno sodelovanje, zato leta 2011 sprejme konvencijo Medicrime. Tako dobimo tudi prvo in edino mednarodno pogodbo, ki inkriminira dejanja na tem področju. V misiji preprečevanja ponarejanja zdravil imajo nezanemarljivo vlogo tudi ostale mednarodne institucije, kot sta Svetovna zdravstvena organizacija in Evropska agencija za zdravila, ter nacionalne institucije, Javna agencija za zdravila in medicinske pripomočke, Zavod za preverjanje avtentičnosti zdravil in mnoge druge vladne in nevladne organizacije. V diplomskem delu so predstavljene omenjene institucije in njihova vloga v boju proti ponarejenim zdravilom. Predstavljena je tudi strategija izbranega farmacevtskega podjetja na tem področju in njihovi preventivni ukrepi, načini odkrivanja morebitnih ponarejenih zdravil in ukrepi v primeru odkritega ponaredka.
Keywords:diplomske naloge, ponarejena zdravila, zakonodaja, preprečevanje, Evropska unija, javno zdravje
Year of publishing:2021
Year of performance:2021
Place of performance:Ljubljana
Publisher:[A. Škrgić]
Number of pages:VII, 50 str.
Source:Ljubljana
UDC:343.347:615(043.2)
COBISS_ID:64445187 New window
NUK URN:URN:SI:UM:DK:UNTXGDJS
Views:218
Downloads:58
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Categories:FVV
:
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:20.07.2020

Secondary language

Language:English
Title:Measures of selected pharmaceutical company in the field of falsified medicines
Abstract:The existence of falsified medical products is a global problem which represents an unacceptable risk to public health. It harms patients and undermines trust in the pharmaceutical industry, healthcare professionals and healthcare system. The European Union with its legislation has taken a major step in the fight against falsified medicines over the last decade. Slovenia issued a new Medicines Act in 2014, due to the implementation of European regulations in its legal order. The Council of Europe believes that international cooperation is a key to successfully combating the distribution of falsified medicines, therefore in year 2011 adopted the Medicrime Convention. With Medicrime Convention we obtain the first and only international treaty that incriminate criminal actions in this area. Other international institutions, such as the World Health Organization and the European Medicines Agency, also have a significant role in the mission to prevent counterfeiting of medicines. As well as national institutions - the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP), the Institute for the Authentication of Medicinal Products (ZAPAZ) and many other governmental and non-governmental organizations. This diploma thesis presents aforementioned institutions and their role in the combating against falsified medicines. It also presents the strategy of selected pharmaceutical company in this field and their preventive measures, their ways of detecting potential falsified medicines and actions in case of detected falsification.
Keywords:falsified medicines, prevention, legislation, European Union, public health


Comments

Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica